Impact of High Dose Lorazepam on Seizure Threshold in Catatonia: Experience from a Case Study

نویسندگان

  • Sujita Kumar Kar
  • Saurabh Kumar
  • Amit Singh
چکیده

TO THE EDITOR Catatonia is a well known psychomotor disturbance, commonly associated with mood disorders followed by schizophrenia; mutism being the most common symptom. Patients with catatonia often respond to high dose of benzodiazepine or electroconvulsive therapy (ECT); however, the combination of benzodiazepine and ECT is also reported to be safe and effective in patients of catatonia. A 20 years old male, presenting with mutism, rigidity, negativism, posturing and holding food and saliva in mouth since five days, was hospitalized. History revealed thought broadcasting and auditory hallucinations (commanding and commenting type) since last eight months and was on irregular treatment. Catatonic symptoms were also present two months back which partially responded to 6 mg/day lorazepam, but resolved completely after one session of ECT. His routine blood investigations were within normal limits. Magnetic resonance imaging of brain did not reveal any pathology. The patient was diagnosed with schizophrenia. The patient had left the hospital against medical advice and become non-adherent to treatment in few days, which caused relapse of his catatonic symptoms. During current hospitalization, initially he was treated with ECT alone (57 mC dose with seizure duration of 37 seconds), but due to inadequate response, subsequently lorazepam was added. Dose of lorazepam gradually increased from 8 mg/day to18 mg/day along with alternate day ECT. The patient had effective seizures with duration ranging from 35 to 42 seconds with same dose of ECT (57 mC). After seven sessions ECT was stopped and subsequently, he was maintained on lorazepam (18 mg/day) along with antipsychotic olanzapine (15 mg/day) with adequate control of psychotic symptoms including catatonia. The patient did not report any adverse effects to this combination of medications. Seizure threshold is an important parameter to decide the dose of ECT. Medications like benzodiazepines, barbiturate and antiepileptics commonly increase the seizure threshold. In this case, the patient was receiving very high dose of lorazepam (18 mg per day in divided doses) along with ECT without any alteration in seizure threshold. It is well known that low dose of benzodiazepine and use of benzodiazepines 48 hours prior to administration of ECT does not affect the seizure threshol. This case gives a message that despite of high dose of benzodiazepine, the seizure threshold may remain unaltered. ECT can be safe and effective along with high dose of benzodiazepine.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Catatonic Syndrome : Treatment Response to Lorazepam

Sir, We read with interest the study by Payee et al. (1999). Authors remark that no study on the treatment of catatonia with lorazepam has been carried out in India. In this context, we would like to mention that a similar but more exhaustive study has been conducted by us on a larger patient population at Central Institute of Psychiatry, Ranchi. We share a few findings from our study, which is...

متن کامل

Intramuscular lorazepam in catatonia in patients with acute renal failure: a report of two cases.

Cases of catatonia in patients with renal failure have been rarely reported. In this report, we describe two renal-insufficient patients with catatonia who had a good response to intramuscular lorazepam whereby the catatonic symptoms were relieved. Case 1 involved a patient with end-stage renal disease and severe pneumonia related respiratory failure. He responded well to intramuscular lorazepa...

متن کامل

Rapid relief of catatonia in mood disorder by lorazepam and diazepam.

BACKGROUND Catatonia has risks of severe morbidity and mortality and needs early treatment. In this study, we investigated more patients to discuss the efficacy of this treatment in patients with major depressive disorder (MDD) or bipolar I disorder (BPI). METHODS During a period of 9 years, we identified 12 catatonic patients with mood disorder, with MDD (n = 10) and BPI (n = 2) in the emerg...

متن کامل

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription

OBJECTIVES To describe a case of neuroleptic malignant syndrome following antipsychotic treatment of catatonia, highlighting the potentially serious complications of this rare adverse drug reaction. METHODS We present a case report of a patient who developed this syndrome with various sequelae. RESULTS The patient developed neuroleptic after being treated with lorazepam and olanzapine for c...

متن کامل

Malignant catatonia responsive to low doses of lorazepam: case report.

CONTEXT Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype. CASE REPORT This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 14  شماره 

صفحات  -

تاریخ انتشار 2016